Functional studies undertaken by the same researchers suggested that loss of JAK2 function in melanoma cells could impairs IFN signaling, causing resistance to T cell-mediated cytotoxicity and thereby leading to recurrence of the melanoma15,17. This evidence concerns the gene JAK2 and melanoma.